Drug firm Ipca Laboratories today reported a standalone net loss of Rs 20.25 crore for the first quarter ended June, mainly on account of dip in... ...http://www.business-standard.com/article/pti-stories/ipca-labs-q1-net-loss-at-rs-20-25-cr-117081100669_1.html
Posted by Equitymaster Indian share markets continued to flourish in green during the noon session and were trading well above the dotted line.... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/dD0kwknWvBA/tm.asp
Posted by Equitymaster Crude oil prices fell by 4.5% during the week. The correction took place post the US government data reflecting that the... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/9bWUoeLjNks/tm.asp
The US drug regulator Food and Drug Administration (FDA) has banned all drug imports from the Mumbai based mid-cap drug company Ipca Laboratories... ...http://www.businesstoday.in/sectors/pharma/us-bans-imports-of-drug-from-three-ipca-lab-facilities-shares-fall/story/254594.html
Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4% Benchmark indices swung between gains and losses... ...http://www.rediff.com/money/report/how-the-markets-fared-on-june16/20170616.htm
Minocycline is a broad-spectrum...